Publications found:
369
Sort by:
Biobetters Market - 2025-2033
US$ 2,999.00
The Biobetters Market was valued at US$ 58.30 Billion in 2025 and is anticipated to reach US$ 112.03 Billion by 2033, at a CAGR of 0.085 from 2026 to 2032. The report delivers in-depth insights into k...
April 2026
207 pages
Advanced Ceramics Market - Strategic Insights and Forecasts (2026-2031)
US$ 3,950.00
Advanced Ceramics Market is projected to grow to US$104.854 billion by 2021, from US$63.112 billion in 2015, at a compound annual growth rate of 8.83%. Advanced ceramics are manufactured to overcome the ... new applications is also expected to boost the market growth over the forecast period. However, the advanced ceramics market faces many limitations such as component cost ...
April 2026
146 pages
Biologics Contract Development And Manufacturing Organization Market Size, Share & Trends Analysis Report By Product (Monoclonal Antibodies, Recombinant Proteins & Enzymes), By Service, By Source, By Workflow, By Therapeutic Area, By End Use, By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global biologics contract development and manufacturing organization market size was estimated at USD 47.84 billion in 2025 and is projected to reach USD 84.91 billion by 2033, growing at a CAGR o...
April 2026
120 pages
Lentiviral Vector Market Size, Share & Trends Analysis Report By Product (1st-Generation, 2nd-Generation, 3rd-Generation), By Indication (HIV, ?-Thalassemia), By End Use (Academic and Research Institute, CROs & CMOs), By Region, And Segment Forecasts, 2026 - 2033
US$ 5,950.00
The global lentiviral vector market size was valued at USD 601.1 million in 2025 and is projected to reach USD 1,140.6 million by 2033, growing at a CAGR of 8.4% from 2026 to 2033. Growth is driven by...
April 2026
120 pages
Next Generation Drug Conjugates Market by Product (Enhertu, Amvuttra), Type (Antibody-Small Molecule), Target Ligand (Antibody, Peptide), Payload Type (Oligonucleotide, Radionuclide), Indication (Breast Cancer, Prostate Cancer) - Global Forecast to 2035
US$ 4,950.00
The global next generation drug conjugates market is estimated to reach USD 42.55 billion by 2035 from USD 15.75 billion in 2026, at a CAGR of 11.7% during the forecast period of 2026 to 2035. The glo...
April 2026
331 pages
Global Targeted Protein Degradation Market Size Study and Forecast by Type (Degronimids, Immunomodulatory Drugs (IMiDs), Proteolysis-targeting chimeric molecules (PROTACs), Sudden Acquired Retinal Degeneration Syndrome (SARDs), Selective Estrogen Receptor Degraders (SERDs), Specific Bromodomain and Extra-Terminal Domain (BET) and Deubiquitinases (DUB) Inhibitors), Therapeutic Area (Inflammatory Disorders, Neurological Disorders, Oncological Disorders, Respiratory Disorders, Other Therapeutic Areas), Route of Administration (Oral, Intravenous, Others), Application (Hospital, Research Institute), and Regional Forecasts 2026-2035
US$ 3,750.00
The targeted protein degradation (TPD) market encompasses a novel class of therapeutic modalities designed to selectively degrade disease-causing proteins rather than merely inhibiting their function....
April 2026
285 pages
Peptide Therapeutics Market 2026
US$ 2,999.00
The Peptide Therapeutics Market was valued at in and is anticipated to reach by , at a CAGR of 0.078 from 2026 to 2032. The report delivers in-depth insights into key market dynamics, including region...
April 2026
207 pages
PEGylated Proteins Market Report by Product (Consumables, Services), Protein Type (Colony Stimulating Factors, Interferons, Erythropoietin, mAbs, Recombinant Factor VII, and Others), Application (Cancer Treatment, Hepatitis, Chronic Kidney Diseases, Hemophilia, Multiple Sclerosis, Gastrointestinal Disorders, and Others), End User (Pharmaceutical and Biotechnology Companies, Contract Research Organizations, Academic and Research Institutes), and Region 2026-2034
US$ 2,999.00
The global PEGylated proteins market size reached USD 1.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 3.1 Billion by 2034, exhibiting a growth rate (CAGR) of 8.09% du...
April 2026
142 pages
Regenerative Medicine Market Report by Type (Stem Cell Therapy, Biomaterial, Tissue Engineering, and Others), Application (Bone Graft Substitutes, Osteoarticular Diseases, Dermatology, Cardiovascular, Central Nervous System, and Others), End User (Hospitals, Specialty Clinics, and Others), and Region 2026-2034
US$ 2,999.00
The global regenerative medicine market size reached USD 31.8 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 143.3 Billion by 2034, exhibiting a growth rate (CAGR) of 17...
April 2026
136 pages
Autologous Stem Cell and Non-Stem Cell Based Therapies Market Report by Type (Autologous Stem Cells, Autologous Non-Stem Cells), Application (Cancer, Neurodegenerative Disorders, Cardiovascular Disease, Orthopedic Diseases, and Others), End User (Hospitals, Ambulatory Surgical Centers, Research Facilities), and Region 2026-2034
US$ 2,999.00
The global autologous stem cell and non-stem cell based therapies market size reached USD 9.5 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 24.3 Billion by 2034, exhibi...
April 2026
145 pages
Plasma Fractionation Market Report by Product (Immunoglobulins, Albumin, Coagulation factor VIII, Coagulation factor IX), Sector (Private Sector, Public Sector), Application (Neurology, Immunology, Hematology, and Others), End User (Hospitals and Clinics, Clinical Research Laboratories, Academic Institutes), and Region 2026-2034
US$ 2,999.00
The global plasma fractionation market size reached USD 27.7 Billion in 2025. Looking forward, the market is expected to reach USD 42.3 Billion by 2034, exhibiting a growth rate (CAGR) of 4.67% during...
April 2026
148 pages
Antibody Drug Conjugates Market Report by Component (Monoclonal Antibodies, Linker, Cytotoxic Agent, and Others), Target (Antibody-Protein Toxin Conjugates, Antibody-Chelated Radionuclide Conjugates, Antibody-Small-Molecule Drug Conjugates, Antibody-Enzyme Conjugates), Application (Lymphoma, Ovarian Cancer, Lung Cancer, Breast Cancer, Brain Tumor, and Others), End User (Hospitals, Specialized Cancer Centers, Academic Research Institutes, Biotechnology Companies, and Others), and Region 2026-2034
US$ 2,999.00
The global antibody drug conjugates market size reached USD 11.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 54.8 Billion by 2034, exhibiting a growth rate (CAGR) of...
April 2026
145 pages
Asia Pacific Erythropoietin Drugs Market Size, Share, Trends & Analysis by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa, Others), by Application (Cancer, Renal Disease, Neurology, Others) and Region, with Forecasts from 2025 to 2034.
US$ 3,590.00
The Asia Pacific Erythropoietin (EPO) Drugs Market is expected to witness substantial growth from 2025 to 2034, driven by rising prevalence of chronic kidney disease (CKD), cancer-related anemia, and...
March 2026
215 pages
Europe Erythropoietin Drugs Market Size, Share, Trends & Analysis by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa, Others), by Application (Cancer, Renal Disease, Neurology, Others) and Region, with Forecasts from 2025 to 2034.
US$ 3,590.00
The Europe Erythropoietin (EPO) Drugs Market is projected to witness steady growth from 2025 to 2034, driven by increasing prevalence of chronic kidney disease (CKD), cancer-related anemia, and other...
March 2026
211 pages
Global Erythropoietin Drugs Market Size, Share, Trends & Analysis by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa, Others), by Application (Cancer, Renal Disease, Neurology, Others) and Region, with Forecasts from 2025 to 2034.
US$ 3,890.00
The Global Erythropoietin (EPO) Drugs Market is projected to witness robust growth from 2025 to 2034, driven by the increasing prevalence of chronic kidney disease, cancer-related anemia, and other he...
March 2026
227 pages
North America Erythropoietin Drugs Market Size, Share, Trends & Analysis by Type (Biologics, Biosimilars), by Product (Erythropoietin, Darbepoetin-alfa, Others), by Application (Cancer, Renal Disease, Neurology, Others) and Region, with Forecasts from 2025 to 2034.
US$ 3,590.00
The North America Erythropoietin (EPO) Drugs Market is anticipated to record steady growth from 2025 to 2034, supported by the high prevalence of chronic kidney disease (CKD), cancer-related anemia, a...
March 2026
213 pages
Global Filgrastim and Biosimilars Market Growth 2026-2032
US$ 3,660.00
The global Filgrastim and Biosimilars market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Filgrastim is a recombin...
March 2026
142 pages
Global Sargramostim Market Growth 2026-2032
US$ 3,660.00
The global Sargramostim market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Sargramostim is a recombinant form of...
March 2026
77 pages
Global RGD Peptide Market Growth 2026-2032
US$ 3,660.00
The global RGD Peptide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. RGD peptide is a binding motif of fibro...
March 2026
143 pages
Global Bicyclic Peptide Market Growth 2026-2032
US$ 3,660.00
The global Bicyclic Peptide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Bicyclic Peptide is a type of shor...
March 2026
78 pages
Global Branched Peptide Market Growth 2026-2032
US$ 3,660.00
The global Branched Peptide market size is predicted to grow from US$ million in 2025 to US$ million in 2032; it is expected to grow at a CAGR of %from 2026 to 2032. Branched peptide is a type of pept...
March 2026
119 pages
Japan Biologic Drug Lifecycle Management Market - 2024-2033
US$ 2,999.00
The Japan Biologic Drug Lifecycle Management Market was valued at US$ 4.61 Billion in 2024 and is anticipated to reach US$ 9.69 Billion by 2033, at a CAGR of 0.086 from 2026 to 2032. The report delive...
February 2026
212 pages
